Abstract:
Utility scores quantify health-related quality of life (HRQOL) along a continuum that typically ranges from 0.0 (dead) to 1.0 (full health), and are essential in developing summary measures of population health (SMPH), as well as performing cost-effectiveness analysis (CEA) of different treatments and intervention strategies. A key methodological issue is that traditionally, utility scores have been developed primarily for single health conditions, even though comorbidities are common in both general and patient populations.
Inaccuracies in health measurement are likely to occur when comorbidity is ignored in the estimation of utility scores. In this chapter, methodological issues and advances with regard to deriving utility scores for comorbid health conditions are reviewed.
Direct utility elicitation protocols such as the standard gamble (SG) or time trade-off (TTO) are the most theoretically desirable approaches, but are cognitively burdensome for raters. With population survey data, scores from utility-based HRQOL instruments (e.g., the Health Utilities Index) can often be computed for self-reported comorbidities, but this strategy is often constrained by the limited number of conditions queried, as well as potentially compromised by self-report bias. Another suggested, yet little-used strategy is to map the expected impact of a given comorbidity into the descriptive system of a generic, multiattribute utility instrument, and then compute the corresponding utility score with the scoring algorithm.
Convenient mathematical models (e.g., additive, multiplicative, minimum) for combining single-condition utility scores have also been proposed, but the empirical evidence for their performance is mixed, as well as difficult to assess due to a lack of standardization in utility instrumentation and analytical procedures used. An “encompassing” mathematical model that subsumes traditional models as special cases appears to be more accurate, but has only been examined with respect to directly elicited utilities in the prostate cancer context. A crucial next step is evaluating its performance with respect to a wider variety of health conditions and data sources.
In future work on evaluating and refining methods for obtaining comorbidity-related utilities, cross-study comparability can be enhanced by striving for more consistency in utility instrumentation and analytical techniques.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 15D:
-
15-Dimensions Index
- BoD:
- CCHS:
-
Canadian Community Health Survey
- CCC:
-
Clinical Classification Category
- CEA:
-
cost-effectiveness analysis
- CHF:
-
congestive heart failure
- CLAMES:
-
Classification and Measurement System of Functional Health
- COPD:
-
chronic obstructive pulmonary disease
- D:
-
disutility score
- EQ-5D:
-
EeuroQol Five Dimensions Index
- GBoD:
-
global burden of disease
- HRQOL:
-
health-related quality of life
- HUI3:
-
Health Utilities Index Mark III
- ICD-9:
-
International Classification of Diseases-Ninth Revision
- IHD:
-
Ischemic Heart Disease
- MEPS:
-
Medical Expenditures Panel Survey
- NPHS:
-
Canadian National Population Health Survey
- ODD:
-
Ontario Diabetes Database
- OHS:
-
Ontario Health Survey
- PAR:
-
population attributable risk
- PCEHM:
-
Panel on Cost-Effectiveness in Health and Medicine
- PTO:
-
person trade-off
- QALY:
-
quality-adjusted life year
- QBW:
-
Quality of Well-Being Index
- QWB-SA:
-
Quality of Well-Being Index – Self-Administered
- RR:
-
relative risk
- SF-6D:
-
Short-Form Six Dimensions Index
- SES:
-
socio-economic status
- SG:
-
standard gamble
- SMPH:
-
summary measure of population health
- TTO:
-
time trade-off
- U:
-
utility score
- WHO:
-
World Health Organization
References
Andrews G, Sanderson K, Beard J. (1998). Br J Psychiatry. 173: 123–131.
Arnesen T, Nord E. (1999). BMJ. 319: 1423–1425.
Austin PC. (2002). Med Decis Making. 22: 152–162.
Basu A, Dale W, Elstein A, Meltzer D. (2008). J. Health Econ. Sep4 [Epub ahead of print] PMID: 18773392.
Begg S, Vos T, Barker B, Stevenson C, Stanley L, Lopez A. (2007). Burden of disease and injury in Australia, 2003. AIHW cat. no. PHE 82. Australian Bureau of Health and Welfare, Canberra.
Bell CM, Chapman RH, Stone PW, Sandberg EA, Neumann PJ. (2001). Med. Decis. Making. 21: 288–294.
Boswell-Purdy J, Flanagan WM, Roberge H, Le Petit C, White KJ, Berthelot JM. (2007). Chron Dis Can. 28: 42–55.
Bowker SL, Pohar SL, Johnson JA. (2006). Health Qual Life Outcomes. 4: 17.
Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. (2005). JAMA. 294: 716–724.
Bravata DM, Nelson LM, Garber AM, Goldstein MK. (2005). Med Decis Making. 25: 158–167.
Brazier J, Deverill M, Green C, Harper R, Booth A. (1999). Health Technol. Assess. 3: 1–164.
Broemeling A-M, Watson D, Black C. (2005). Chronic conditions and comorbidity among residents of British Columbia. Centre for Health Services and Policy Research, University of British Columbia, British Columbia.
Brown MM, Brown GC, Sharma S. (2005). Evidence-based to value-based medicine. AMA, Chicago, Illinois.
Clarke P, Gray A, Holman R. (2002). Med Decis Making. 22: 340–349.
Coffey JT, Brandle M, Zhou H, Marriott D, Burke R, Tabaei BP, Engelgau MM, Kaplan RM, Herman WH. (2002). Diabetes Care 25: 2238–2243.
Dale W, Basu A, Elstein A, Meltzer D. (2008). Med Decis Making. 28: 102–112.
Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddardt GL. (2005). Methods for the economic evaluation of health care programmes, 3rd ed. Oxford University Press, Oxford.
Eckman MH, Steere AC, Kalish RA, Pauker SG. (1997). N Engl J Med. 337: 357–363.
Eckman MH, Falk RH, Pauker SG. (1998). Arch Intern Med. 158: 1669–1677.
Eckman MH, Singh SK, Erban JK, Kao G. (2002). Med Decis Making. 22: 106–124.
Feeny DA. (2005). ISOQoL Res. Newsletter 10: 1 and 8.
Feeny D, Furlong W, Torrance GW, Goldsmith CH, Zhu Z, DePauw S, Denton M, Boyle M. (2002). Med Care 40: 113–128.
Flanagan W, McIntosh CN, Le Petit C, Berthelot JM. (2006). PHM. 4: 13.
Fortin M, Lapointe L, Hudon C, Vanasse A, Ntetu AL, Maltais D. (2004). Health Qual. Life Outcomes. 20: 51.
Franci DM, Pathak DV. (2003). Int J Technol. Assess. Health Care 19: 347–361.
Franks P, Hanmer J, Fryback DG. (2006). Med Care. 44: 478–485.
Fryback D, Lawrence W. (1997). Med Decis Making. 17: 276–284.
Fu A, Kattan M. (2008). Med Care. 46: 984–990.
Furlong W, Barr RD, Feeny D, Yandow S. (2005). Health Qual. Life Outcomes. 3: 3.
Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, Bos GA. van den (2001). J Clin Epidemiol. 54: 661–674.
Gold MR, Siegel JE, Russell LB, Weinstein MC. (1996). Cost-Effectiveness in Health and Medicine. Oxford University Press, Oxford.
Hall WH, Jani AB, Ryu JK, Narayan S, Vijayakumar S. (2005). Prostate Cancer Prostatic Dis. 8: 22–30.
Harris R, Nease R. (1997). J Health Econ. 16: 113–120.
Hazen G. (2004). Decis Analysis. 1: 205–216.
Johnston JA, Brill-Edwards P, Ginsberg JS, Pauker SG, Eckman MH. (2005). Am J Med. 118: 503–514.
Kao TC, Cruess DF, Garner D, Foley J, Seay T, Friedrichs P, Thrasher JB, Mooneyhan RD, McLeod DG, Moul JW. (2000). J Urol. 163: 858–864.
Katzmarzyk PT, Janssen I. (2004). Appl. Physiol. Nutr. Metab. 29: 90–115.
Knight SJ, Nathan DP, Siston AK, Kattan MW, Elstein AS, Collela. (2002). Clin Prostate Cancer 1:105–14.
Laux G, Kuehlein T, Rosemann T, Szecsenyi J. (2008). BMC Health Serv Res. 8: 14.
Maddigan SL, Feeny DH, Johnson JA. (2005). Qual Life Res. 14: 1311–1320.
Maddigan SL, Feeny DH, Majumdar SR, Farris KB, Johnson JA. (2006). Am J Public Health. 96: 1649–1655.
Manuel DG, Schultz SE. (2004). PHM 2: 4.
Manuel DG, Schultz SE, Kopec JA. (2002). J Epidemiol Community Health 56: 843–850.
Mas-Colell A, Whinston MD, Green JR. (1995). Microeconomic theory. Oxford University Press, New York.
Mathers CD, Iburg KM, Begg SB. (2006). PHM 4:4.
Mathers CD, Sadana R, Salomon JA, Murray CJL, Lopez AD. (2001). Lancet. 357: 1685–1691.
Mathers C, Vos T, Stevenson C. (1999). The burden of disease and injury in Australia. Australian Institute of Health and Welfare, AIHW cat. no. PHE 17. Australian Bureau of Health and Welfare, Canberra.
McIntosh CN, Gorber SC, Bernier J, Berthelot JM. (2007). Chron Dis Can. 28: 29–41.
Murray CJL. (1996). In: Murray CJL, Lopez AD (ed). The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020, Volume 1. Harvard University Press, Boston, pp. 1–98.
Murray CJL, Lopez AD. (2000). Health Econ. 9: 69–82.
Murray CJL, Salomon JA, Mathers CD, Lopez AD (eds). (2002). Summary measures of population health: Concepts, ethics, measurement and applications. World Health Organization, Geneva.
Naglie G, Krahn MD, Naimark D, Redelmeier DA, Detsky AS. (1997). Med Decis Making. 17: 136–141.
Quan H, Parsons GA, Ghali WA. (2002). Med Care. 40: 675–685.
Ritvo P, Irvine J, Naglie G, Tomlinson G, Bezjak A, Matthew A, Trachtenberg J, Krahn M. (2005). J Clin Epidemiol. 58: 466–474.
Rutten-van-Mölken MPMH, Oostenbrink JB, Tashkin, DP, Burkhart D, Monz BU. (2006). Chest. 130: 1117–1128.
Salomon JA, Murray CJL. (2004). Health Econ. 13: 281–290.
Saarni S, Härkänen T, Sintonen H, Suvisaari J, Koskinen S, Aromaa A, Lönnqvist J. (2006). Qual. Life Res. 15: 1403–1414.
Schultz SE, Kopec JA. (2003). Health Rep. 14: 41–53.
Statistics Canada. (2002–2003). National Population Health Survey: Health Institutions Component Cycle 5. http://www.statcan.ca/english/sdds/instrument/5003_Q1_V5_E.pdf.
Stewart ST, Lenert L, Bhatnagar V, Kaplan RM. (2005). Med Care. 43: 347–355.
Stouthard MEA, Essink-Bot ML, Bonsel GJ, Barendregt JJM, Kramers PGN, van de Water HPA, Gunning-Schepers LJ, van der Maas PJ. (1997). Disability weights for diseases in the Netherlands. Department of Public Health, Erasmus University, Rotterdam.
Sullivan PW, Ghushchyan V. (2006). Med Decis Making. 26: 410–420.
Sullivan PW, Lawrence WF, Ghushchyan V. (2005). Med Care. 43: 736–749.
Tengs T, Wallace A. (2000). Med Care. 38: 583–637.
Tunis S, Stryer DB, Clancy CM. (2003). JAMA. 290: 1624–1632.
US Bureau of the Census. (1992). International Population Reports, an Aging World II. P25, 92–3. US Government Printing Office, Washington DC
van Baal PHM, Hoeymans N, Hoogenveen RT, de Wit GA, Westert GP. (2006). PHM 4: 1
Vos T, Begg S. (2000). The Victorian Burden of Disease Study: Morbidity. Public Health Division, Department of Human Services, Melbourne.
Wu SY, Green A. (2000). Projection of Chronic Illness Prevalence and Cost Inflation. RAND Health, Washington DC.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media LLC
About this entry
Cite this entry
McIntosh, C.N. (2010). Utility Scores for Comorbid Conditions: Methodological Issues and Advances. In: Preedy, V.R., Watson, R.R. (eds) Handbook of Disease Burdens and Quality of Life Measures. Springer, New York, NY. https://doi.org/10.1007/978-0-387-78665-0_20
Download citation
DOI: https://doi.org/10.1007/978-0-387-78665-0_20
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-78664-3
Online ISBN: 978-0-387-78665-0
eBook Packages: MedicineReference Module Medicine